Ardelyx reported $47.84M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Abbott ABT:US $ 12647M 458M
Amgen AMGN:US $ 12886M 702M
Ardelyx ARDX:US $ 47.84M 4.98M
Astrazeneca AZN:US $ 22740M 146M
Biocept BIOC:US $ 14.1M 2.32M
Chimerix CMRX:US $ 15.21M 14.68M
Corcept Therapeutics CORT:US $ 57.24M 9.7M
Curis CRIS:US $ 9.69M 3.75M
Life Technologies LIFE:US $ 6.27M 0.26M
Opko Health OPK:US $ 309.17M 20.84M
Tg Therapeutics TGTX:US $ 54.66M 10.73M
United Therapeutics UTHR:US $ 292.6M 12.8M
Xoma XOMA:US $ 7.89M 5.08M